By targeting RNA rather than DNA, Amber Bio aims to treat multiple genetic diseases with fewer safety risks.Gene-editing technology using Crispr holds a lot of promise for treating genetic disorders like type 1 diabetes and sickle cell anemia. There are currently studies right now that have demonstrated effectiveness by actually changing patients DNA to correct […]
